Results 11 to 20 of about 53 (52)
ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES
Рациональная фармакотерапия в кардиологии, 2015 Review of current ideas about the role of acetylsalicylic acid (ASA) in the primary prevention of cardiovascular disease is presented. Data on reduction in malignant neoplasms incidence rate in long-term use of the drug, as well as prospects for further ...
E. N. Dankovtseva
doaj +1 more source
ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG?
Рациональная фармакотерапия в кардиологии, 2015 The results of recent trials on acetylsalicylic acid (ASA) efficacy are presented. Data potentially related to the possibility of ASA indications extension is discussed, in particular that referring to the cancer prevention. This ASA indication should be
I. V. Zhirov
doaj +1 more source
Siberian Journal of Life Sciences and Agriculture, 2019 In order to study hemostasis in sensitive and acetylsalicylic acid (ASA) resistant patients with ischemic heart disease (IHD), 53 patients with IHD were examined. Patients are divided into groups sensitive and resistant to ASA.
Maxim Dmitrievich Goncharov +2 more
doaj +1 more source
ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE?
Рациональная фармакотерапия в кардиологии, 2015 Use of acetylsalicylic acid (ASA) in cardiology practice is presented. ASA modes of action and the main indications are discussed. ASA use for primary cardiovascular diseases prevention and its possible side effects are considered especially ...
S. A. Boldueva, I. A. Leonova
doaj +1 more source
Siberian Journal of Life Sciences and Agriculture, 2019 In order to study the characteristics of neutrophil chemiluminescent activity in sensitive and acetylsalicylic acid (ASK) resistant patients with ischemic heart disease (IHD), 53 patients with IHD were examined.
Andrey Evgenievich Vselov
doaj +1 more source
Рациональная фармакотерапия в кардиологии, 2015 Aim. To compare effects of acetylsalicylic acid (ASA) and two clopidogrel drugs on residual platelet aggregative reactivity (RPAR). Material and methods.
A. A. Lomonosova +5 more
doaj +1 more source
Атеротромбоз, 2015 Сердечно-сосудистые заболевания являются причиной более половины летальных случаев в России. Среди них ишемическая болезнь сердца и инфаркт миокарда являются одними из наиболее значимых, ассоциированных с высокой летальностью.
О. В. Аверков
doaj +1 more source
GASTROENTEROPATHIES ASSOCIATED WITH ACETYLSALICYLIC ACID: HOW TO IMPROVE SAFETY OF THERAPY
Рациональная фармакотерапия в кардиологии, 2016 Lesion of gastrointestinal mucous coat is the main factor limited acetylsalicylic acid (ASA) use in patients with atherothrombosis. Up to date the mostly comprehensible way to decrease gastrointestinal complications is taking ASA in the lowest effective ...
A. L. Komarov
doaj +1 more source
RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA
Рациональная фармакотерапия в кардиологии, 2015 Aim. To estimate the prevalence of atherothrombotic complications depending on platelet sensitivity to acetylsalicylic acids (ASA) in patients with stable angina.Material and methods.
N. F. Putchinyan +2 more
doaj +1 more source
Атеротромбоз, 2014 Статья посвящена обсуждению вопросов приверженности к применению двойной антитромбоцитарной терапии (ДАТ) у пациентов, перенесших острый коронарный синдром (ОКС) или перенесших коронарное стентирование.
doaj +1 more source